Press Releases - 2023-09-22

Date	Title	Company
22-Sep-2023	Alzamend Neuro Granted Extension by Nasdaq Panel to Regain Compliance with the Minimum Bid Price Continued Listing Requirement	Businesswire
22-Sep-2023	Navigating the Beauty Landscape: Dermal Fillers Market Set for 7.5% CAGR through 2023-2033, \| FMI Reports	MARKITWIRED
22-Sep-2023	FMI Unveils Middle East Veterinary Vaccines Market’s Remarkable Journey Towards a US$ 533.4 Million Valuation by 2031, Fueled by a 4.8% CAGR	MARKITWIRED
22-Sep-2023	Charting the Future of Nerve Repair Market: FMI’s Latest Report Forecasts a Resilient 12.2% CAGR, Reaching US$ 861.4 Million by 2033	MARKITWIRED
22-Sep-2023	Compression Garments and Stockings Market Eyes US$ 3.9 Billion by 2029 with a 4.9% CAGR \| FMI	MARKITWIRED
22-Sep-2023	Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations	Veranova
22-Sep-2023	Future Insights: Russia’s Viscosupplementation Market Set to Achieve US$ 84.86 Million by 2032 with a 6.2% CAGR \| FMI	MARKITWIRED
22-Sep-2023	Prefilled Syringes Market Size & Share Analysis Report 2023 - Global Growth Trends & Forecasts to 2028 Featuring Key Players - BD & Co, Terumo, Gerresheimer, SCHOTT, & West Pharmaceutical Services - ResearchAndMarkets.com	Businesswire
22-Sep-2023	Bristol Myers Squibb Announces Perioperative Regimen of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer	Businesswire
22-Sep-2023	Merck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer	Businesswire
22-Sep-2023	PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial	Businesswire
22-Sep-2023	THOUSANDS WITH INCURABLE CANCER TO GET FIVE YEARS’ REMISSION THANKS TO PIONEERING TREATMENT	Myeloma UK
22-Sep-2023	NHS and Government take steps to boost Organ donation registrations	NHS Blood and Transplant
22-Sep-2023	ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs	The Institute of Cancer Research, London
22-Sep-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
22-Sep-2023	National Institute for Health and Care Excellence gives green light to Darzalex® (daratumumab) with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma	Janssen UK
22-Sep-2023	Arthroscopy Visualization Systems Market US$ 902.5 Million by 2032, at a CAGR of 7.1%: Driven by Increasing Prevalence of Musculoskeletal Disorders \| FMI	MARKITWIRED
22-Sep-2023	NICE RECOMMENDS LILLY’S MIRIKIZUMAB (OMVOH ®▼) FOR THE TREATMENT OF ELIGIBLE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS	Eli Lilly & Co.
22-Sep-2023	Breast Biopsy Devices Market On a Trajectory to Reach US$ 3.6 Billion by 2032, Growing at a Steady CAGR of 5.5% \| FMI	MARKITWIRED
22-Sep-2023	Arriello appoints experienced biotech expert, Kate Coleman, as VP of Quality & Compliance	Arriello